Pathological complete response to neoadjuvant trastuzumab and pertuzumab therapy is related to human epidermal growth factor receptor 2 (HER2) amplification level in HER2-amplified breast cancer
在HER2扩增型乳腺癌中，新辅助曲妥珠单抗和帕妥珠单抗治疗的病理完全缓解与人表皮生长因子受体2 (HER2) 扩增水平相关。
期刊:Medicine
影响因子:1.4
doi:10.1097/MD.0000000000023053
Choi, Jin Hyuk; Jeon, Chang Wan; Kim, Young Ok; Jung, Sungui
